Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU5F-3P (RNA, U5F small nuclear 3, pseudogene) is a genomic locus annotated as a pseudogene for a small nuclear RNA of the U5 family[3]. Pseudogenes are typically noncoding DNA segments derived from functional genes that have lost their ability to encode an active product, often through sequence mutation or genomic rearrangement[6]. While some pseudogenes can be transcribed, they are generally not translated into functional RNA or protein products. The U5 small nuclear RNAs are normally components of the spliceosome, which is a multi-RNA/protein complex responsible for pre-mRNA splicing in eukaryotic cells[1]. However, RNU5F-3P specifically lacks documented protein products, known function, or clinical relevance, and is not categorized as a therapeutic target or biomarker for disease. There is no evidence from current databases or the literature that this pseudogene is transcribed, functional, or implicated in regulation, disease pathogenesis, or pharmacological interaction[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U5F small nuclear 3, pseudogene (RNU5F-3P).